While it may seem like healthcare CIOs are thinking about cybersecurity and about the future of Meaningful Use, those issues are less important to many health IT professionals than the transition to value-based payments.
That’s according to Carla Smith, executive vice president of the Healthcare Information and Management Systems Society, which holds its annual conference next week in Las Vegas. HIMSS will share more details of its yearly CIO survey Tuesday morning, but Smith gave MedCity News a small preview in a podcast interview this week.
Other findings she hinted at are that IT has become a “strategically critical tool” for successful healthcare providers nationwide and that there is a correlation between the strategic value placed on IT and organizations who have clinical IT executives. More organizations are including clinical IT executives like chief medical information officers and chief nursing information officers in strategic decisions — typically reporting directly to the CFO or CEO — though it’s still not a majority, Smith said.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
As usual, the endurance event known as the HIMSS conference keep growing. Attendance could approach 50,000, far above the record of 45,000 that came to HIMSS15 in Chicago, and the exhibit hall will include more than 1,300 vendors.
Smith called attention to a session with Centers for Medicare and Medicaid Services Administrator Andy Slavitt and national health IT coordinator Dr. Karen DeSalvo at 5:30 Pacific time Tuesday. They plan on keeping their prepared remarks brief and will take a lot of questions, Smith said, and she encouraged the health IT community to tweet their questions with the hashtag #HIMSS16.
Listen to the podcast below.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
